Summary.-A series of patients with a variety of histopathologically confirmed cancers have been examined using the MOD-MEM test as described by Pritchard et al. (1973) . Despite the closest possible adherence to the experimental protocols recommended by these authors, no positive reactions to the test were observed in this series: neither were we able to demonstrate the release of a "macrophage-slowing factor" by a panel of normal donors when challenged with tubercle PPD. We conclude that the test has no present application to the diagnosis of cancer.
IN 1970, Field and his colleagues introduced a novel method of detecting lymphocyte sensitization to specific antigens (Caspary, Hughes and Field, 1970; . The method resembles the assay of inhibition of macrophage migration (David et al., 1964) in that target macrophages are used to detect a putative effector substance released by sensitized lymphocyte populations following incubation with the appropriate antigen. The released material brings about a diminution in the electrophoretic mobility (EPM) of macrophages (from guinea-pig peritoneal exudates) when in free suspension. An earlier report (Diengdoh and Turk, 1968) had described a similar electrophoretic slowing of peritoneal cells from tuberculin-sensitized guinea-pigs after a 60-min in vivo exposure to PPD.
Although first developed and applied by Field in the area of demyelinating neurological diseases, at an early stage ) the technique was extended to the diagnosis of cancer, following demonstration of sensitivity towards the encephalitogenic basic protein of myelin (MBP) among peripheral blood lymphocytes from patients with proved malignant disease. Since this first publication, several other groups have reported on the application of the test to the detection of cancer. Some of these, notably Pritchard et al. (1972) , Preece and Light (1974) and Irmscher et al. (1975) have claimed to confirm Field and Caspary's original findings, whereas others (Lewkonia, Kerr and Irvine, 1974; Crozier et al., 1976 ) have failed to demonstrate any clear-cut differences in response between patients with malignant disease, individuals with nonmalignant chronic inflammatory conditions, and presumptively normal controls. From a rather larger series, Rawlins, Wood and Bagshawe (1976) The first publications from Field's laboratory dealt with sensitivity in cancer patients to MBP. Later papers (Caspary and Field, 1971; Carnegie et al., 1973) In his various reviews of the MEM test (e.g. 1973) , Field clearly regards it as having an immunological basis and reflecting the immune status of the lymphocytes of the donor with respect to the putative antigen. Indeed, the test has also been used to detect a rapid mixed lymphocyte reaction as an aid to tissue typing (Field, 1972 Breeding Unit. Originally, SPF Category 4 Star (MRC Accreditation Scheme) guinea-pigs were used, but when these became unavailable they wAere replaced by Category 2 Star animals. The guinea-pigs were kept in a room isolated from other animals, in filter boxes or laminar flow cabinets. Bedding, food and drinking water, to which vitamin C was added, were all sterile. The bacteriological status of the animals was monitored for up to 6 weeks under this regime, and the results from this testing demonstrated the efficacy of the measures employed in preventing adventitious infections. Further, no symptoms of colds or influenza-like infections were observed in any of the animals during the course of the investigations.
Exudates were raised by the i.p. injection of 10 ml liquid paraffin B.P., and the cells harvested 7-16 days after the injection. It is well known that the size and cellular composition of peritoneal exudates varies with different batches of liquid paraffin. Only oils producing a consistently high proportion > 50%o) of droplet-bearing cells were used in this series of tests. Freshly killed guineapigs were opened along the midline and the peritoneal cavity was washed out 2-3 tinies using 80-100 ml TC199, and the cell suspension transferred to glass centrifuge tubes. The cells were washed x 3 in TC199 and a suspension prepared of 107 cells/ml. The cells were exposed to 180 rad of 220 kV X-rays before use.
Antigens.-The encephalitogenic (MBP) myelin basic protein was prepared from human brain following Caspary and Field (1965) by defatting with chloroform/methanol and acetone, extracting with HCI at pH 3 0 and chromatographing the crude MBP on Sephadex G-100 in 10 mM HCI. On polyacrylamide gel electrophoresis by the method of Johns (1967) the major band eoineides in mobility with the major band in samples of MBP given by Dr J. P. Dickinson and by Professor A. N. Davison. A minor band having a mobility equal to that of globin is present in all 3 samples. This component behaves like MBP in gel filtration on Sephadex G-100, ion exchange chromatography on CM-cellulose, fractional precipitation with acetone, and 'isoelectric" precipitation at pH 10-5. The biological activity of MBP prepared as above was confirmed by the induction of experimental allergic encephalomyelitis (histopathologically confirmed) in guinea-pigs with doses down to 10 Hug/ animal administered with Freund's complete adjuvant intradermally over the sternum.
For the preparation of "cancer basic protein" (Caspary and Field, 1971; Carnegie et al., 1973) a basic protein, said to be present on the external surface of the cell membrane of all cancer cells, which behaves similarly in the MEM test to MBP , various surgical and postmortem human tumour specimens, HeLa cells, and crude membrane preparations from tumours or HeLa cells, were subjected to defatting and acid extraction as in the preparation of MBP. On gel electrophoresis, most of these extracts were found to have, as their major components, proteins whose banding patterns were identical to those of human histones; no major component, and no minor consistent component, with a mobility close to that of MBP was observed. These preparations did not cause macrophage slowing in the MEM test with lymphocytes from normal individuals or cancer patients.
MBP was used in the MEM test at a final concentration of 33 jug/ml. We also used a peptide derived from cancer basic protein of human tumour tissue prepared by Dr J. P. Dickinson, which was used at an unknowvin but reputedly effective concentration. PPD was obtained from the Central Veterinary Laboratory, Weybridge.
Glassu are. All glassware used was washed strictly according to a protocol recommended by Dr Pritchard. After soaking overnight in 10°Chloros the glassware was rinsed and transferred to 1% liquid Labrite for a further 24 h before being rinsed in 10 changes each of hot tapwater, cold tapwater and distilled water; double glass distilled water was used for the last 2 rinses. None of the glassware was siliconized.
Medium.-TC199 writh Hanks' salts and bicarbonate-buffered was made up from Gibco-Biocult powdered medium using double-glass-distilled water. The conductivity of each batch was checked using an LKB Conductolyzer and, if necessary, adjusted to provide an electrophoresis medium of constant electrical properties, specific resistance 67-3 Q/cm. MOD-MEM methodology.-The MOD-MEM method of Pritchard et al. (1973) was used for all samples tested during this series. 'Macrophage slowing factor" (MSF) was prepared by incubating 106 lymphocytes suspended in 2 ml TC199 with antigen at the appropriate concentration for 90 min at room temperature. Supernatants from these, and from control tubes set up without antigen, were either used immediately for a secondstage incubation with guinea-pig macrophages or stored at -40°C for subsequent examinaton. Samples for electrophoresis were prepared by taking 107 peritoneal exudate cells in 1 ml TC199 and incubating with 2-ml aliquots of lymphocyte supernatants for 90 min at 37°C. The samples were allowed to cool to about 25°C before being introduced slowly into the eytopherometer chamber. Samples were randomized by an uninvolved colleague: on most occasions duplicate series w%ere set up and examined by at least 2 operators.
Measuring technique. Determinations of EPM were made in a Zeiss Cytopherometer.
Macrophages of about 16 ,um diameter containing 2 or 3 ingested oil droplets were selected for timing (Shenton, Hughes and Field, 1973) . Percentage slowing was calculated using the formula (Te-T)/T, x 100 where T, is the mean time for cells in the control sample and Te that for cells in the test sample (Caspary and Field, 1971 (Lewkonia et al., 1974; Crozier et al., 1976; Rawlins et al., 1976) . These other workers have generally reported a wide scatter of results from both normal and patient groups, with considerable overlap between groups leading to both "false-positive" and "false-negative" results. In contrast, our results show comparatively small scatter and offer no evidence for the existence of a "macrophage slowing factor" in the supernatants tested.
A number of authors, when discussing the MEM test (Lewkonia et al., 1974; Field and Shenton, 1975; Crozier et al., 1976; Fraser and Hancock, 1976) , have commented upon the technical difficulties surrounding successful operation of the Zeiss Cytopherometer. One of the present authors (J.A.F.) has had some 15 years' experience of cell electrophoretic techniques and has been familiar with the Zeiss instrument since its introduction in 1964. The present series of patients, selected using the strict criteria set out in the Materials section, was only undertaken after about a year's experience of the technique and investigation of various experimental aspects of the test system by two other authors. The values listed in the Table demonstrate the consistency of electrophoretic measurement which can be achieved after proper familiarization with the instrument. It has long been recognized that well washed erythrocytes are electrophoretically a highly homogeneous population of cells and they have been generally used as a standard for checking the calibration of cell electrophoresis instruments. The coefficient of variation of such populations, calculated from measurements on samples of 10-20 cells is of the order of 2.5% (Seaman and Heard, 1960) . This probably represents, as a combination of biological variability on the one hand and uncertainty in the physical determination on the other, the limit of resolution of the cell electrophoretic method. The greater scatter of the target macrophage populations recorded in the Table presumably reflects, therefore, greater biological variation in the population under study, and accords with other published data on nucleated cells (see Forrester, 1975) . Indeed, one can only achieve this degree of precision with peritoneal exudate cells if the morphological criteria laid down by Shenton et al. (1973) The values in that column were then treated statistically to yield parameters which were attributed to the population as a whole. In a series of 38 samples of 10 macrophages, each from untreated populations, we observed a total of 10 such cells which were more than 12% slower than the expected mean, i.e. a frequency of 2.6%. Because of this low rate of occurrence of slow cells in our exudates we have not adopted the 2-column system, but have simply recorded the first 10 cells which fulfilled the morphological criteria for responsive cells. In Fig. 2 WVe must therefore conclude that in our hands treatment of isolated blood lymphocytes from cancer patients with MBP or other materials does not result in the release of a "macrophage-slowing factor". We should mention here that we have been unable to demonstrate the slowing phenomenon in other systems, including multiple sclerosis using MBP as 'antigen' (Smith and Forrester, in preparation) and in tuberculin-sensitized guinea-pigs using PPD. Our failure to observe slowing when lymphocytes from normal human donors are challenged with PPD, upon which Field has laid much stress (vide Field and Shenton, 1975) , accords with the experience of Pritchard (personal communication) . In another system, Fraser and Hancock (1976) have been unable to confirm the application of the MEM test to the laboratory diagnosis of scrapie in sheep.
It is clear that it is not possible to reconcile the results described here with reports from other laboratories confirming the validity of the MEM test in cancer. It may be that there is some flaw in our methods of cell handling which has vitiated ouir attempts to reproduce the test. If this is so then it has withstood a most careful scrutiny of our techniques in conjunction with Dr J. A. V. Pritchard.
